Private Capital Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,047
| Closed | -$475K | – | 84 |
|
|
2023
Q3 | $475K | Hold |
6,047
| – | – | 0.07% | 60 |
|
|
2023
Q2 | $466K | Hold |
6,047
| – | – | 0.08% | 57 |
|
|
2023
Q1 | $502K | Hold |
6,047
| – | – | 0.09% | 55 |
|
|
2022
Q4 | $519K | Hold |
6,047
| – | – | 0.09% | 53 |
|
|
2022
Q3 | $373K | Hold |
6,047
| – | – | 0.06% | 59 |
|
|
2022
Q2 | $374K | Hold |
6,047
| – | – | 0.06% | 64 |
|
|
2022
Q1 | $359K | Hold |
6,047
| – | – | 0.05% | 80 |
|
|
2021
Q4 | $439K | Hold |
6,047
| – | – | 0.07% | 60 |
|
|
2021
Q3 | $422K | Sell |
6,047
-250
| -4% | -$17.6K | 0.07% | 72 |
|
|
2021
Q2 | $434K | Sell |
6,297
-1,360
| -18% | -$90.8K | 0.07% | 73 |
|
|
2021
Q1 | $495K | Hold |
7,657
| – | – | 0.09% | 67 |
|
|
2020
Q4 | $446K | Hold |
7,657
| – | – | 0.09% | 67 |
|
|
2020
Q3 | $484K | Sell |
7,657
-100
| -1% | -$6.93K | 0.11% | 67 |
|
|
2020
Q2 | $597K | Sell |
7,757
-150
| -2% | -$11.5K | 0.15% | 54 |
|
|
2020
Q1 | $591K | Hold |
7,907
| – | – | 0.19% | 50 |
|
|
2019
Q4 | $514K | Hold |
7,907
| – | – | 0.13% | 62 |
|
|
2019
Q3 | $501K | Hold |
7,907
| – | – | 0.14% | 66 |
|
|
2019
Q2 | $534K | Hold |
7,907
| – | – | 0.15% | 64 |
|
|
2019
Q1 | $514K | Sell |
7,907
-300
| -4% | -$19.9K | 0.16% | 66 |
|
|
2018
Q4 | $513K | Hold |
8,207
| – | – | 0.18% | 63 |
|
|
2018
Q3 | $634K | Hold |
8,207
| – | – | 0.18% | 69 |
|
|
2018
Q2 | $581K | Hold |
8,207
| – | – | 0.18% | 64 |
|
|
2018
Q1 | $619K | Buy |
8,207
+1,082
| +15% | +$86K | 0.21% | 66 |
|
|
2017
Q4 | $510K | Sell |
7,125
-5,332
| -43% | -$405K | 0.18% | 75 |
|
|
2017
Q3 | $1.01M | Hold |
12,457
| – | – | 0.34% | 52 |
|
|
2017
Q2 | $882K | Sell |
12,457
-712
| -5% | -$47.4K | 0.29% | 69 |
|
|
2017
Q1 | $894K | Sell |
13,169
-340
| -3% | -$23.9K | 0.29% | 68 |
|
|
2016
Q4 | $967K | Sell |
13,509
-2,278
| -14% | -$169K | 0.33% | 65 |
|
|
2016
Q3 | $1.25M | Buy |
15,787
+4,593
| +41% | +$373K | 0.45% | 56 |
|
|
2016
Q2 | $934K | Hold |
11,194
| – | – | 0.35% | 58 |
|
|
2016
Q1 | $1.03M | Hold |
11,194
| – | – | 0.46% | 57 |
|
|
2015
Q4 | $1.13M | Hold |
11,194
| – | – | 0.49% | 58 |
|
|
2015
Q3 | $1.1M | Hold |
11,194
| – | – | 0.46% | 58 |
|
|
2015
Q2 | $1.31M | Hold |
11,194
| – | – | 0.43% | 66 |
|
|
2015
Q1 | $1.1M | Sell |
11,194
-10,697
| -49% | -$1.09M | 0.4% | 63 |
|
|
2014
Q4 | $2.06M | Sell |
21,891
-2,803
| -11% | -$290K | 0.78% | 53 |
|
|
2014
Q3 | $2.63M | Buy |
24,694
+13,500
| +121% | +$1.32M | 0.85% | 53 |
|
|
2014
Q2 | $928K | Sell |
11,194
-22,000
| -66% | -$1.71M | 0.3% | 75 |
|
|
2014
Q1 | $2.35M | Sell |
33,194
-13,700
| -29% | -$1.07M | 0.9% | 48 |
|
|
2013
Q4 | $3.52M | Buy |
46,894
+23,200
| +98% | +$1.62M | 1.21% | 41 |
|
|
2013
Q3 | $1.49M | Sell |
23,694
-50,500
| -68% | -$3.02M | 0.54% | 60 |
|
|
2013
Q2 | $3.8M | Buy |
+74,194
| New | +$3.87M | 1.41% | 26 |
|
Other funds holding GILD
Private Capital Advisors's GILD Position: Q4 2023 in Review
Private Capital Advisors sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 6,047 shares — an estimated $475K sold.
Private Capital Advisors first reported a position in GILD in Q2 2013 and held it in 42 quarters. The position peaked at $3.8M in Q2 2013. 1,776 funds tracked by Wall St. Rank hold GILD as of Q4 2023.
- Private Capital Advisors reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
- Private Capital Advisors sold 6,047 Gilead Sciences shares in Q4 2023, an estimated $475K.
- Private Capital Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 42 quarters.
- Private Capital Advisors's Gilead Sciences position peaked at $3.8M in Q2 2013.
- 1,776 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.
Based on Private Capital Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.